A Case of Onychomycosis Caused by Rhodotorula glutinis

Rhodotorula spp. have emerged as opportunistic pathogens, particularly in immunocompromised patients. The current study reports a case of onychomycosis caused by Rhodotorula glutinis in a 74-year-old immunocompetent female. The causative agent was identified as R. glutinis based on the pinkish-orang...

Full description

Saved in:
Bibliographic Details
Main Authors: Hatice Uludag Altun, Tuba Meral, Emel Turk Aribas, Canan Gorpelioglu, Nilgun Karabicak
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:Case Reports in Dermatological Medicine
Online Access:http://dx.doi.org/10.1155/2014/563261
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832555446468083712
author Hatice Uludag Altun
Tuba Meral
Emel Turk Aribas
Canan Gorpelioglu
Nilgun Karabicak
author_facet Hatice Uludag Altun
Tuba Meral
Emel Turk Aribas
Canan Gorpelioglu
Nilgun Karabicak
author_sort Hatice Uludag Altun
collection DOAJ
description Rhodotorula spp. have emerged as opportunistic pathogens, particularly in immunocompromised patients. The current study reports a case of onychomycosis caused by Rhodotorula glutinis in a 74-year-old immunocompetent female. The causative agent was identified as R. glutinis based on the pinkish-orange color; mucoid-appearing yeast colonies on Sabouraud Dextrose Agar at 25°C; morphological evaluation in the Corn Meal-Tween 80 agar; observed oval/round budding yeast at 25°C for 72 hours; no observed pseudohyphae; positive urease activity at 25°C for 4 days; and assimilation features detected by API ID 32C kit and automated Vitek Yeast Biochemical Card 2 system. Antifungal susceptibility test results were as follows: amphotericin B (MIC = 0.5 µg/mL), fluconazole (MIC = 128 µg/mL), itraconazole (MIC = 0.125 µg/mL), voriconazole (MIC = 1 µg/mL), posaconazole (MIC = 0.5 µg/mL), anidulafungin (MIC = 0.5 µg/mL), and caspofungin (MIC = 16 µg/mL). Antifungal therapy was initiated with oral itraconazole at a dose of 400 mg/day; seven-day pulse therapy was planned at intervals of three weeks. Clinical recovery was observed in the clinical evaluation of the patient before the start of the third cure. Although R. glutinis has rarely been reported as the causative agent of onychomycosis, it should be considered.
format Article
id doaj-art-07b53e413c5540e989145604fc78ca46
institution Kabale University
issn 2090-6463
2090-6471
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series Case Reports in Dermatological Medicine
spelling doaj-art-07b53e413c5540e989145604fc78ca462025-02-03T05:48:03ZengWileyCase Reports in Dermatological Medicine2090-64632090-64712014-01-01201410.1155/2014/563261563261A Case of Onychomycosis Caused by Rhodotorula glutinisHatice Uludag Altun0Tuba Meral1Emel Turk Aribas2Canan Gorpelioglu3Nilgun Karabicak4Department of Clinical Microbiology, Faculty of Medicine, Turgut Ozal University, Emek, 06510 Ankara, TurkeyDepartment of Clinical Microbiology, Faculty of Medicine, Turgut Ozal University, Emek, 06510 Ankara, TurkeyDepartment of Clinical Microbiology, Faculty of Medicine, Turgut Ozal University, Emek, 06510 Ankara, TurkeyDepartment of Dermatology, Faculty of Medicine, Turgut Ozal University, Emek, 06510 Ankara, TurkeyMycology Reference Laboratory, Public Health Institution of Turkey, Sıhhıye, 06100 Ankara, TurkeyRhodotorula spp. have emerged as opportunistic pathogens, particularly in immunocompromised patients. The current study reports a case of onychomycosis caused by Rhodotorula glutinis in a 74-year-old immunocompetent female. The causative agent was identified as R. glutinis based on the pinkish-orange color; mucoid-appearing yeast colonies on Sabouraud Dextrose Agar at 25°C; morphological evaluation in the Corn Meal-Tween 80 agar; observed oval/round budding yeast at 25°C for 72 hours; no observed pseudohyphae; positive urease activity at 25°C for 4 days; and assimilation features detected by API ID 32C kit and automated Vitek Yeast Biochemical Card 2 system. Antifungal susceptibility test results were as follows: amphotericin B (MIC = 0.5 µg/mL), fluconazole (MIC = 128 µg/mL), itraconazole (MIC = 0.125 µg/mL), voriconazole (MIC = 1 µg/mL), posaconazole (MIC = 0.5 µg/mL), anidulafungin (MIC = 0.5 µg/mL), and caspofungin (MIC = 16 µg/mL). Antifungal therapy was initiated with oral itraconazole at a dose of 400 mg/day; seven-day pulse therapy was planned at intervals of three weeks. Clinical recovery was observed in the clinical evaluation of the patient before the start of the third cure. Although R. glutinis has rarely been reported as the causative agent of onychomycosis, it should be considered.http://dx.doi.org/10.1155/2014/563261
spellingShingle Hatice Uludag Altun
Tuba Meral
Emel Turk Aribas
Canan Gorpelioglu
Nilgun Karabicak
A Case of Onychomycosis Caused by Rhodotorula glutinis
Case Reports in Dermatological Medicine
title A Case of Onychomycosis Caused by Rhodotorula glutinis
title_full A Case of Onychomycosis Caused by Rhodotorula glutinis
title_fullStr A Case of Onychomycosis Caused by Rhodotorula glutinis
title_full_unstemmed A Case of Onychomycosis Caused by Rhodotorula glutinis
title_short A Case of Onychomycosis Caused by Rhodotorula glutinis
title_sort case of onychomycosis caused by rhodotorula glutinis
url http://dx.doi.org/10.1155/2014/563261
work_keys_str_mv AT haticeuludagaltun acaseofonychomycosiscausedbyrhodotorulaglutinis
AT tubameral acaseofonychomycosiscausedbyrhodotorulaglutinis
AT emelturkaribas acaseofonychomycosiscausedbyrhodotorulaglutinis
AT canangorpelioglu acaseofonychomycosiscausedbyrhodotorulaglutinis
AT nilgunkarabicak acaseofonychomycosiscausedbyrhodotorulaglutinis
AT haticeuludagaltun caseofonychomycosiscausedbyrhodotorulaglutinis
AT tubameral caseofonychomycosiscausedbyrhodotorulaglutinis
AT emelturkaribas caseofonychomycosiscausedbyrhodotorulaglutinis
AT canangorpelioglu caseofonychomycosiscausedbyrhodotorulaglutinis
AT nilgunkarabicak caseofonychomycosiscausedbyrhodotorulaglutinis